Logo Carlo Sessa : GPS Coordinates 45.529507 - 9.226839

Carlo Sessa

Yili Chuanning Biotechnology operates advanced pharmaceutical facilities in Shanghai and Xinjiang, producing 16,000 tons of intermediates annually with 68 patents.

Presentation of Carlo Sessa

Yili Chuanning Biotechnology, headquartered in Shanghai’s Xuhui District at the Yanxiang Science Building, leads China’s biotechnology research and development sector. Operating from the Horgos Economic Development Zone, the company maintains:

  • 16,000 tons annual production capacity of pharmaceutical intermediates
  • 68 authorized patents and multiple engineering centers
  • 2.7 billion yuan investment in environmental protection
  • State-of-the-art fermentation facilities

With its recent IPO raising 1.114 billion yuan and strategic presence in both Shanghai and Xinjiang, Yili Chuanning advances sustainable pharmaceutical manufacturing across China.

Carlo Sessa newsfeed

  • Yili Chuanning has not yet been verified. The newsfeed is disabled.

Detailed presentation of Carlo Sessa

A leading biotechnology company in Shanghai

Yili Chuanning Biotechnology, established in 2010, operates from the Yanxiang Science and Technology Building in Shanghai’s Xuhui District. The company has grown into a major player in China’s biotechnology sector, with facilities in the Horgos Economic Development Zone.

Advanced research and production capabilities

As a cosmetic lab and pharmaceutical manufacturer, Yili Chuanning Biotechnology maintains an annual production capacity of 16,000 tons. The company specializes in producing thiocyanate erythromycin, cephalosporin, penicillin intermediates, and UDCA API.

Innovation and research excellence

The company’s commitment to advancement is demonstrated through its research infrastructure, including a national-level innovation platform and three regional engineering technology centers. With 68 authorized patents, including 32 invention patents, Yili Chuanning leads in industrial innovation.

Environmental commitment and sustainable practices

Operating from Shanghai, the company has invested 2.7 billion yuan in environmental protection facilities. This investment represents 34% of total project funding, highlighting their dedication to green manufacturing practices in China’s biotechnology sector.

Production scale and resources

The facility processes significant quantities of raw materials annually:

  • 1.2 million tons of coal
  • 450,000 tons of corn
  • 200,000 tons of soybean meal

Market position and growth

Following its successful IPO in December 2022, Yili Chuanning Biotechnology (stock code 301301) raised 1.114 billion yuan, strengthening its position in Shanghai’s competitive biotechnology market. The company continues to expand its operations while maintaining high standards in research and production.

Services provided by Carlo Sessa

Below you will find the services provided by Yili Chuanning. Like each cosmetic lab on the platform, the services are manually registered by the providing company.

  • Yili Chuanning has no service catalogue on cosmetic-labs.com.

Gallery and medias

  • Yili Chuanning has not yet posted any media. There is no gallery yet.

Locate Carlo Sessa

Contact Carlo Sessa

  • Yili Chuanning has not yet been verified. Messaging is disabled.

Carlo Sessa opening hours

Frequent questions

Yili Chuanning Biotechnology manufactures these pharmaceutical products:

  • Antibiotics
    • Thiocyanate erythromycin
    • Cephalosporin intermediates
    • Penicillin intermediates
  • APIs
    • UDCA (Ursodeoxycholic Acid)

Annual production capacity: 16,000 tons

Raw material processing:

  • 450,000 tons of corn
  • 200,000 tons of soybean meal
  • 1.2 million tons of coal

Yili Chuanning Biotechnology manufactures these pharmaceutical products:

  • Antibiotics
    • Thiocyanate erythromycin
    • Cephalosporin intermediates
    • Penicillin intermediates
  • APIs
    • UDCA (Ursodeoxycholic Acid)

Annual production capacity: 16,000 tons

Raw material processing:

  • 450,000 tons of corn
  • 200,000 tons of soybean meal
  • 1.2 million tons of coal

Yili Chuanning Biotechnology manufactures these pharmaceutical products:

  • Antibiotics
    • Thiocyanate erythromycin
    • Cephalosporin intermediates
    • Penicillin intermediates
  • APIs
    • UDCA (Ursodeoxycholic Acid)

Annual production capacity: 16,000 tons

Raw material processing:

  • 450,000 tons of corn
  • 200,000 tons of soybean meal
  • 1.2 million tons of coal
Explore

Find a cosmetic lab in Italy

Click below to see the profile of a cosmetic lab similar to Carlo Sessa in Italy.

Fairoils cosmetic lab in Aat, Belgium produces natural oils through ethical farming partnerships in Africa, operating facilities in Kenya and Madagascar.
The Nisshin Oillio Group’s cosmetic lab in Yokohama, Japan develops plant-based beauty solutions through research, testing and sustainable ingredient sourcing.
Trace One’s cosmetic lab in Puteaux, France provides product lifecycle management and regulatory compliance solutions across 170+ countries, managing 1M+ safety data sheets annually.
Arborea’s cosmetic lab in England uses Biosolar Leafâ„¢ technology for sustainable protein production and CO2 sequestration while maintaining UK quality standards.
Intercare operates a cosmetic lab and R&D center in Seongnam-si, South Korea, offering formulation development, technical support and ingredient distribution since 1978.
Merieux Nutrisciences operates a cosmetic laboratory in Veneto, Italy, providing testing, certification and regulatory compliance services through its accredited facilities.